A Novel Role for Glyceraldehyde-3-Phosphate Dehydrogenase and Monoamine Oxidase B Cascade in Ethanol-Induced Cellular Damage

Biological Psychiatry

Volumn 67, Issue 9, 2010, Pages 855-863

  Ou, Xiao Ming ^a   Stockmeier, Craig A ^a,b   Meltzer, Herbert Y ^c   Overholser, James C ^b   Jurjus, George J ^b   Dieter, Lesa ^b   Chen, Kevin ^d   Lu, Deyin ^a   Johnson, Chandra ^a   Youdim, Moussa B H ^f   Austin, Mark C ^a   Luo, Jia ^g   Sawa, Akira ^h   May, Warren ^a   Shih, Jean C ^d,e  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^g UNIVERSITY OF KENTUCKY   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcoholism; ethanol induced brain cell dysfunction; glyceraldehyde 3 phosphate dehydrogenase; human brain tissues; monoamine oxidase B; rats fed with an ethanol diet

Indexed keywords

ALCOHOL; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DNA NUCLEOTIDYLEXOTRANSFERASE; ENZYME ACTIVATOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LUCIFERASE; RASAGILINE; SELEGILINE; TRANSFORMING GROWTH FACTOR BETA INDUCIBLE EARLY GENE 2; UNCLASSIFIED DRUG;

ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CELL DAMAGE; CELL FRACTIONATION; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; NEUROBLASTOMA; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA INTERFERENCE;

ALCOHOLISM; ANALYSIS OF VARIANCE; ANIMALS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ETHANOL; GENE EXPRESSION REGULATION; GLIOBLASTOMA; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; HYDROGEN PEROXIDE; IMMUNOPRECIPITATION; IN SITU NICK-END LABELING; MALE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NEUROBLASTOMA; NEURONS; PREFRONTAL CORTEX; RATS; RATS, WISTAR; REPRESSOR PROTEINS; RNA, MESSENGER; SELEGILINE; TRANSFECTION;

EID: 77950367630     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.10.032     Document Type: Article

References (45)

1. Dupont R.M., Rourke S.B., Grant I., Lehr P.P., Reed R.J., Challakere K., et al. Single photon emission computed tomography with iodoamphetamine-123 and neuropsychological studies in long-term abstinent alcoholics. Psychiatry Res 67 (1996) 99-111
2. Ducci F., Enoch M.A., Funt S., Virkkunen M., Albaugh B., and Goldman D. Increased anxiety and other similarities in temperament of alcoholics with and without antisocial personality disorder across three diverse populations. Alcohol 41 (2007) 3-12
3. Kril J.J., and Halliday G.M. Brain shrinkage in alcoholics: A decade on and what have we learned?. Prog Neurobiol 58 (1999) 381-387
4. Brooks P.J. Brain atrophy and neuronal loss in alcoholism: A role for DNA damage?. Neurochem Int 37 (2000) 403-412
5. Prendergast M.A. Do women possess a unique susceptibility to the neurotoxic effects of alcohol?. J Am Med Womens Assoc 1972 (2004) 225-227
6. Prendergast M.A., and Little H.J. Adolescence, glucocorticoids and alcohol. Pharmacol Biochem Behav 86 (2007) 234-245
7. Miguel-Hidalgo J.J., Wei J., Andrew M., Overholser J.C., Jurjus G., Stockmeier C.A., et al. Glia pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms. Biol Psychiatry 52 (2002) 1121-1133
8. Miguel-Hidalgo J.J., Overholser J.C., Meltzer H.Y., Stockmeier C.A., and Rajkowska G. Reduced glial and neuronal packing density in the orbitofrontal cortex in alcohol dependence and its relationship with suicide and duration of alcohol dependence. Alcohol Clin Exp Res 30 (2006) 1845-1855
9. Luo J., West J.R., Cook R.T., and Pantazis N.J. Ethanol induces cell death and cell cycle delay in cultures of pheochromocytoma PC12 cells. Alcohol Clin Exp Res 23 (1999) 644-656
10. Chen C.P., Kuhn P., Chaturvedi K., Boyadjieva N., and Sarkar D.K. Ethanol induces apoptotic death of developing beta-endorphin neurons via suppression of cyclic adenosine monophosphate production and activation of transforming growth factor-beta1-linked apoptotic signaling. Mol Pharmacol 69 (2006) 706-717
11. Carlsson A., Adolfsson R., Aquilonius S.M., Gottfries C.G., Oreland L., Svennerholm L., et al. Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. Adv Biochem Psychopharmacol 23 (1980) 295-304
12. Youdim M.B., Fridkin M., and Zheng H. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases. J Neural Transm 111 (2004) 1455-1471
13. Gerlach M., Double K.L., Youdim M.B., and Riederer P. Potential sources of increased iron in the substantia nigra of parkinsonian patients. J Neural Transm Suppl (2006) 133-142
14. Ou X.M., Chen K., and Shih J.C. Dual functions of transcription factors, transforming growth factor-beta-inducible early gene (TIEG)2 and Sp3, are mediated by CACCC element and Sp1 sites of human monoamine oxidase (MAO) B gene. J Biol Chem 279 (2004) 21021-21028
15. Cook T., Gebelein B., Mesa K., Mladek A., and Urrutia R. Molecular cloning and characterization of TIEG2 reveals a new subfamily of transforming growth factor-beta-inducible Sp1-like zinc finger-encoding genes involved in the regulation of cell growth. J Biol Chem 273 (1998) 25929-25936
16. Du Z.X., Wang H.Q., Zhang H.Y., and Gao D.X. Involvement of glyceraldehyde-3-phosphate dehydrogenase in tumor necrosis factor-related apoptosis-inducing ligand-mediated death of thyroid cancer cells. Endocrinology 148 (2007) 4352-4361
17. Chuang D.M., Hough C., and Senatorov V.V. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu Rev Pharmacol Toxicol 45 (2005) 269-290
18. Hara M.R., Agrawal N., Kim S.F., Cascio M.B., Fujimuro M., Ozeki Y., et al. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 7 (2005) 665-674
19. Bae B.I., Hara M.R., Cascio M.B., Wellington C.L., Hayden M.R., Ross C.A., et al. Mutant huntingtin: Nuclear translocation and cytotoxicity mediated by GAPDH. Proc Natl Acad Sci U S A 103 (2006) 3405-3409
20. Chen R.W., Saunders P.A., Wei H., Li Z., Seth P., and Chuang D.M. Involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: Evidence that GAPDH is upregulated by p53. J Neurosci 19 (1999) 9654-9662
21. Alexander-Kaufman K., James G., Sheedy D., Harper C., and Matsumoto I. Differential protein expression in the prefrontal white matter of human alcoholics: A proteomics study. Mol Psychiatry 11 (2006) 56-65
22. Youdim M.B., Edmondson D., and Tipton K.F. The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7 (2006) 295-309
23. Hara M.R., Thomas B., Cascio M.B., Bae B.I., Hester L.D., Dawson V.L., et al. Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Proc Natl Acad Sci U S A 103 (2006) 3887-3889
24. Maruyama W., Akao Y., Youdim M.B., Davis B.A., and Naoi M. Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol. J Neurochem 78 (2001) 727-735
25. Luo J., and Miller M.W. Platelet-derived growth factor-mediated signal transduction underlying astrocyte proliferation: Site of ethanol action. J Neurosci 19 (1999) 10014-10025
26. Luo J., and Miller M.W. Transforming growth factor beta1-regulated cell proliferation and expression of neural cell adhesion molecule in B104 neuroblastoma cells: Differential effects of ethanol. J Neurochem 72 (1999) 2286-2293
27. Henriksen J.H., Gronbaek M., Moller S., Bendtsen F., and Becker U. Carbohydrate deficient transferrin (CDT) in alcoholic cirrhosis: A kinetic study. J Hepatol 26 (1997) 287-292
28. Yao Z., Zhang J., Dai J., and Keller E.T. Ethanol activates NFkappaB DNA binding and p56lck protein tyrosine kinase in human osteoblast-like cells. Bone 28 (2001) 167-173
29. Ou X.M., Chen K., and Shih J.C. Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. Proc Natl Acad Sci U S A 103 (2006) 10923-10928
30. Ou X.M., Chen K., and Shih J.C. Glucocorticoid and androgen activation of monoamine oxidase A is regulated differently by R1 and Sp1. J Biol Chem 281 (2006) 21512-21525
31. McDonald G.R., Hudson A.L., Dunn S.M., You H., Baker G.B., Whittal R.M., et al. Bioactive contaminants leach from disposable laboratory plasticware. Science 322 (2008) 917
32. Geha R.M., Rebrin I., Chen K., and Shih J.C. Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid. J Biol Chem 276 (2001) 9877-9882
33. First M.B., Gibbon M., and Williams J.B. Structured Clinical Interview for DSM-IV Axis 1 Disorders-Patient Edition (SCID-I/P, Version 2.0) (1995), New York State Psychiatric Institute, New York Biometrics Research
34. Li T.K., Lumeng L., McBride W.J., and Waller M.B. Progress toward a voluntary oral consumption model of alcoholism. Drug Alcohol Depend 4 (1979) 45-60
35. Ou X.M., Storring J.M., Kushwaha N., and Albert P.R. Heterodimerization of mineralocorticoid and glucocorticoid receptors at a novel negative response element of the 5-HT1A receptor gene. J Biol Chem 276 (2001) 14299-14307
36. Liu H., Baliga M., Bigler S.A., and Baliga R. Role of cytochrome P450 2B1 in puromycin aminonucleoside-induced cytotoxicity to glomerular epithelial cells. Nephron Exp Nephrol 94 (2003) e17-e24
37. Tazik S., Johnson S., Lu D., Johnson C., Youdim M.B., Stockmeier C.A., et al. Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis. Neurotox Res 15 (2009) 284-290
38. Sen N., Hara M.R., Kornberg M.D., Cascio M.B., Bae B.I., Shahani N., et al. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nat Cell Biol 10 (2008) 866-873
39. Hara M.R., Cascio M.B., and Sawa A. GAPDH as a sensor of NO stress. Biochim Biophys Acta 1762 (2006) 502-509
40. Youdim M.B., Gross A., and Finberg J.P. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B. Br J Pharmacol 132 (2001) 500-506
41. Graven K.K., Troxler R.F., Kornfeld H., Panchenko M.V., and Farber H.W. Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia. J Biol Chem 269 (1994) 24446-24453
42. Webster K.A., Gunning P., Hardeman E., Wallace D.C., and Kedes L. Coordinate reciprocal trends in glycolytic and mitochondrial transcript accumulations during the in vitro differentiation of human myoblasts. J Cell Physiol 142 (1990) 566-573
43. Duncan J.A., and Storey K.B. Subcellular enzyme binding and the regulation of glycolysis in anoxic turtle brain. Am J Physiol 262 (1992) R517-R523
44. Ou X.M., Lu D., Johnson C., Chen K., Youdim M.B., Rajkowska G., et al. Glyceraldehyde-3-phosphate dehydrogenase-monoamine oxidase B-mediated cell death-induced by ethanol is prevented by rasagiline and 1-R-aminoindan. Neurotox Res 16 (2009) 148-159
45. Youdim M.B. The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30. Curr Alzheimer Res 3 (2006) 541-550